Vertex Pharmaceuticals

VRTX · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.296%

12M weight contribution

+0.044 pp

3M weight contribution

+0.012 pp

12M price return

+24.7%

Share of matched S&P 500 members

Monthly observations through Apr 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Apr 2023	$87.6bn	0.296%	+0.044 pp	+24.7%	Yes
Mar 2023	$81.0bn	0.276%	+0.053 pp	+20.7%	Yes
Feb 2023	$74.6bn	0.262%	+0.059 pp	+26.2%	No
Jan 2023	$82.9bn	0.284%	+0.076 pp	+32.9%	Yes
Dec 2022	$74.1bn	0.267%	+0.089 pp	+31.5%	No
Nov 2022	$81.2bn	0.276%	+0.115 pp	+69.3%	Yes
Oct 2022	$80.1bn	0.284%	+0.124 pp	+68.7%	Yes
Sep 2022	$74.3bn	0.292%	+0.127 pp	+59.6%	Yes
Aug 2022	$72.3bn	0.259%	+0.085 pp	+40.7%	Yes
Jul 2022	$71.7bn	0.246%	+0.067 pp	+39.1%	Yes
Jun 2022	$72.1bn	0.280%	+0.096 pp	+39.8%	Yes
May 2022	$68.7bn	0.247%	+0.054 pp	+28.8%	Yes
Apr 2022	$69.6bn	0.251%	+0.047 pp	+25.2%	Yes
Mar 2022	$66.4bn	0.224%	+0.114 pp	+21.4%	Yes
Feb 2022	$58.6bn	0.203%	+0.093 pp	+8.2%	Yes
Jan 2022	$61.8bn	0.208%	+0.065 pp	+6.1%	Yes
Dec 2021	$55.8bn	0.179%	-0.070 pp	-7.1%	Yes
Nov 2021	$47.5bn	0.161%	-0.091 pp	-17.9%	No
Oct 2021	$48.0bn	0.160%	-0.096 pp	-11.2%	No
Sep 2021	$47.1bn	0.165%	+0.165 pp	-33.3%	No
Aug 2021	$52.0bn	0.174%	+0.173 pp	-28.2%	No
Jul 2021	$52.3bn	0.179%	+0.179 pp	-25.9%	Yes
Jun 2021	$52.2bn	0.184%	+0.184 pp	-30.5%	Yes
May 2021	$54.0bn	0.193%	+0.193 pp	-27.5%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.